NDC 51662-1317
6% HETASTARCH IN 0.9% SODIUM CHLORIDE
6% Hetastarch In 0.9% Sodium Chloride
6% HETASTARCH IN 0.9% SODIUM CHLORIDE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Hetastarch.
| Product ID | 51662-1317_7b97c681-4515-c544-e053-2991aa0a3d78 |
| NDC | 51662-1317 |
| Product Type | Human Prescription Drug |
| Proprietary Name | 6% HETASTARCH IN 0.9% SODIUM CHLORIDE |
| Generic Name | 6% Hetastarch In 0.9% Sodium Chloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-11-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | BA740193 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | HETASTARCH |
| Active Ingredient Strength | 6 g/100mL |
| Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |